Showing results (1361-1370 of 1,376) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|August 2, 2026
Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trialMatthew C L Phillips, Ziad Thotathil, Nur Azri Bin Haji Mohd Yasin, et al.Neuro-Oncology Advances|August 8, 2026
Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomasCharles A Conrad, Sigmund H Hsu, Neil Thapar, et al.Neuro-Oncology Advances|August 8, 2026
Spontaneous cellular senescence and stress response heterogeneity in human vestibular schwannomasSandra Franco-Caspueñas, Carmen Ruiz-García, Julio Contreras, et al.Neuro-Oncology Advances|August 25, 2026
Deep learning-based detection of pediatric brain tumor presence on MRIEstefania Reyes Soto, Silvia Hidalgo Tobón, Dulce Judith Almanza Aranda, et al.Neuro-Oncology Advances|August 23, 2026
Stem-like TCF1+CD8+ T cells are associated with improved survival in male glioblastoma patientsJuyeun Lee, Jesper Dupont Ewald, Rikke H Dahlrot, et al.Neuro-Oncology Advances|August 21, 2026
Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: A multicenter retrospective studyAkihiro Inoue, Makoto Ohno, Yawara Nakamura, et al.Neuro-Oncology Advances|August 19, 2026
Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapyEugenia Cella, Maurizio Polano, Marta Padovan, et al.Neuro-Oncology Advances|September 11, 2026
Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traitsJoana Peixoto, Miguel Castanho, Bárbara Soares-Ferreira, et al.Neuro-Oncology Advances|September 10, 2026
A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetateCarolyn O Dirain, Stuart A Grossman, Xiaobu Ye, et al.Pageof 138